Avtor/Urednik		Zielinski, C; Beslija, S; Červek, J; Mrsič-Krmpotič, Z; Tchernozemsky, I; Witschke, C; Ghilezan, N; Grgič, M; Jassem, J; Tzekova, V
Naslov		Gemcitabine/Epirubicin/Paclitaxel (GET) vs. 5-Fluorouracil/Epirubicin/Cyclophosphamide (FEC) as first-line treatment in metastatic breast cancer: interim toxicity analysis of a randomised, multicenter phase III trial of the central European cooperative oncology group (CECOG)
Tip		članek
Vir		Program/Proc - Am Soc Clin Oncol
Vol. in št.		Letnik 20
Leto izdaje		2001
Obseg		str. 53b
Jezik		eng